Person looking into a microscope.

Rezolute’s challenge was to recruit pediatric, ultra-rare disease patients for a congenital hyperinsulism clinical trial. See how Citeline Connect helped by launching a patient-centric trial education website, deploying prescreeners for caregivers to check children’s eligibility, and looping in recruitment partners.

Our study’s site through Citeline Connect gave us a streamlined, single-source tool that facilitated our collaborative efforts with rare disease advocacy groups around the world to generate awareness about our study and efficiently, effectively recruit potential study participants. The Citeline Connect team was responsive and helpful throughout the development, launch and active phases of our site enabling us to focus on study execution.
Davelyn Hood, MD, MBA, Director of Scientific and Patient Affairs at Rezolute

Related resources

Comforting patient with clapsed hands
SEP 06, 2023
Article
Clinical

How Advocacy Groups Can Motivate Patients to Participate in Clinical Trials

Patient advocacy groups can play a key role in educating patients about ― and ultimately enrolling them in ― clinical trials.

Several hands, adorned with gloves, united to form a heart.
OCT 18, 2023
Article
Patient Engagement & Recruitment

Patients Front and Center: Involving the Patient in Clinical Trial Design

The pharma industry continues to look for ways to boost patient recruitment. See patient, caregiver, and benefits provider perspectives on this issue.

this image depicts Ellers-Danlos Syndrome, a genetic disorder affecting connective tissue.
JUN 08, 2023
Article
Patient Engagement & Recruitment

A 26-year Journey to Reach a Complex Rare Disease Diagnosis

It took Haley Quinn 26 years to get a correct diagnosis of her multiple symptoms. Learn about her journey, and her passion for advocacy.